Hossein Javid

18PUBLICATIONS
26CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMicro- and nanosystemsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 08, 2026
Emerging frontiers in adoptive cell therapies: engineering innovations, current challenges, and manufacturing perspectives.

|Jul 13, 2026
Modified Dendritic cells as a therapeutic platform in hematologic malignancies with translational insights from central nervous system tumors.

|May 18, 2026
Synergistic engineering of pH-responsive MSN@ZIF-8 core-shell nanohybrids for targeted cancer therapy: from rational design to clinical potential.

|Dec 02, 2024
Synergistic cancer treatment using porphyrin-based metal-organic Frameworks for photodynamic and photothermal therapy.

Mahsa Akbari Oryani, Mojtaba Tarin, Leila Rahnama Araghi

|Feb 13, 2024
RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin-RGD interactions.

Hossein Javid, Mahsa Akbari Oryani, Nastaran Rezagholinejad

|Feb 13, 2024
Nanoformulated meloxicam and rifampin: inhibiting quorum sensing and biofilm formation in Pseudomonas aeruginosa.

Malihe Khorramdel, Fatemeh Peyravii Ghadikolaii, Seyed Isaac Hashemy

Pageof 3

Frequent Collaborators

7 joint publications

Seyed Isaac Hashemy

7 joint publications

Mehdi Karimi-Shahri

2 joint publications

Alireza Hashemzadeh

2 joint publications

Reza Assaran Darban